Skip to main content
MEDS
NASDAQ Life Sciences

Corexa Pharmacy Tops $1M Monthly Revenue, Up 66% Since July

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Consumer
Sentiment info
Positive
Importance info
7
Price
$3.49
Mkt Cap
$10.062M
52W Low
$0.823
52W High
$73
52W Position info
324% above low
Off High info
95% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

MEDS has more than doubled off its 52-week low of $0.823 on light trading volume (0.1× avg).

Summary

Corexa Pharmacy, a division of DataMeds AI's wholly owned subsidiary, recorded preliminary unaudited revenue of more than $1 million for September 2026, a jump of over 66% from July. The growth is attributed to the rebranding completed early in Q3, the launch of Tollo Health's dietary supplements and medical foods, and an expanding retail customer base. This follows the recent Helomics acquisition and the rollout of the Health Lives Here mobile app, which positions Corexa as a fulfillment option for telehealth prescriptions. The company is also upgrading its physical location to serve as a flagship model for its network of over 6,500 independent pharmacies. While the revenue figure is modest relative to the company's overall losses and going-concern status, the rapid sequential growth in a key operating segment is a tangible positive signal for the turnaround narrative.

At the time of this announcement, MEDS was trading at $3.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.1M. The 52-week trading range was $0.82 to $73.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

MEDS - Latest Insights

MEDS
Nov 16, 2026, 8:42 AM EST
Filing Type: PRE 14C
Importance Score:
8
Price at Filing: $0.7001
Real-time Price: $1.55 info
Change: +$0.8499 (+121%) info
Market Cap: $7.662M info
MEDS
Nov 16, 2026, 6:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.710
Real-time Price: $1.55 info
Change: +$0.840 (+118%) info
Market Cap: $7.662M info
MEDS
Nov 13, 2026, 5:12 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7251
Real-time Price: $1.55 info
Change: +$0.8249 (+114%) info
Market Cap: $7.662M info
MEDS
Nov 13, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7499
Real-time Price: $1.55 info
Change: +$0.8001 (+107%) info
Market Cap: $7.662M info
MEDS
Nov 13, 2026, 10:20 AM EST
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.8795
Real-time Price: $1.55 info
Change: +$0.6705 (+76%) info
Market Cap: $7.662M info